Updates on Aplastic Anemia and PNH from ASH2021, ASCO2022, and EHA2022 @AAMDSIF

Uploaded January 2025 | Updated September 2026, 3 days ago

In this webinar, Dr. Phillip Scheinberg discusses research most relevant to patients reported over the past year on the biology and treatment on Aplastic Anemia and PNH. These studies were presented at the American Society of Hematology (ASH) 2021, European Hematology Association (EHA) 2022 and American Society of Clinical Oncology (ASCO)2022. Research findings are explained along with the potential impact of this research on understanding and treating aplastic anemia and PNH. This is an advanced scientific presentation.
For more webinars like this, please visit the AAMDSIF recordings page here: aamds.org/webinar/updates-aplastic-anemia-and-pnh-ash-2021-asco-2022-and-eha-2022-meetings

Updates on Aplastic Anemia and PNH from ASH2021, ASCO2022, and EHA2022

AML Session Summary for Patients with Mikkael Sekeres - Secondary AML and Transplantation

Addressing Barriers and Challenges to Patient Care - 2023 Omaha Patient and Family Hybrid Conference

Non-Transplant Therapies for Marrow Failure with Dr. Bhavisha Patel and Dr. Phillip Scheinberg

2022 Webinar: When Does a PNH Clone Have Clinical Significance?

AAMDSIF 40th Anniversary Summit: Advances in the Science and Treatment of PNH

Transplant for MDS in Older Adults - with Mariam Nawas

Updates from ASH22: Aplastic Anemia and PNH with Emma Groarke, MD

Cutaneous Graft versus Host Disease - Diagnosis and Treatment

Understanding Low Risk MDS 2021 Fall Patient Family Conference

AAMDSIF 40th Anniversary Summit: Advances in the Science and Treatment of MDS